Patient education program to enhance decision autonomy in multiple sclerosis relapse management: A randomized-controlled trial

Multiple Sclerosis

Volumn 15, Issue 1, 2009, Pages 96-104

  Köpke, Sascha ^a   Kasper, J ^a   Muhlhauser I ^a   Nubling M ^b   Heesen, C ^c  

^a UNIVERSITY OF HAMBURG   (Germany)

^b GEB Gesellschaft für Empirische Beratung mbH Empirical Consulting   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Decision making; Decision support technique; Glucocorticoids; Multiple sclerosis; Patient education; Patient participation

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY SEVERITY; DRUG MEGADOSE; EDUCATION PROGRAM; FEMALE; GERMANY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PATIENT AUTONOMY; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT PARTICIPATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; DISABILITY EVALUATION; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PAMPHLETS; PATIENT EDUCATION AS TOPIC; PERSONAL AUTONOMY; QUALITY OF LIFE; RECURRENCE;

EID: 58149101117     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508095921     Document Type: Article

References (34)

1. Weinshenker BG Bass B Rice GP. The natural history of multiple sclerosis: A geographically based study. 2. Predictive value of the early clinical course. Brain 1989; 112: 1419-1428.
2. Liu C Blumhardt LD. Assessing relapses in treatment trials of relapsing and remitting multiple sclerosis: Can we do better. Mult Scler 1999; 5: 22-28.
3. Richards RG Sampson FC Beard SM Tappenden P. A review of the natural history and epidemiology of multiple sclerosis: Implications for resource allocation and health economic models. Health Technol Assess 2002; 6: 1-73.
4. Young PJ Lederer C Eder K. Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis. Neurology 2006; 67: 804-808.
5. Confavreux C Vukusic S Moreau T Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-1438.
6. Goodin DS Frohman EM Garmany GP. Disease modifying therapies in multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002; 58: 169-178.
7. Rieckmann P. Multiple Sklerose Therapie Konsensus Gruppe (MSTKG), Immunmodulatorische Stufentherapie der Multiplen Sklerose: Aktuelle Therapieempfehlungen (September 2006). [Escalating immunomodulatory therapy of multiple sclerosis: Update (September 2006).] Nervenarzt 2006; 77: 1506-1518.
8. http://www.rcplondon.ac.uk/pubs/books/MS/MSfulldocument.pdf
9. Tremlett HL Luscombe DK Wiles CM. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom. J Neurol Neurosurg Psychiatry 1998; 65: 362-365.
10. Filippini G Brusaferri F Sibley WA. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database Syst Rev 2000; (4): CD001331.
11. Köpke S Heesen C Kasper J Mühlhauser I. Steroid treatment for relapses in multiple sclerosis - the evidence urges shared decision-making. Acta Neurol Scand 2004; 110: 1-5.
12. Sellebjerg F Frederiksen JL Nielsen PM Olesen J. Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS. Neurology 1998; 51: 529-534.
13. Kasper J Köpke S Mühlhauser I Heesen C. Evidence-based patient information about treatment of multiple sclerosis - a phase one study on comprehension and emotional responses. Patient Educ Couns 2006; 62: 56-63.
14. Whitney SN McGuire AL McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004; 140: 54-59.
15. Towle A Godolphin W. Framework for teaching and learning informed shared decision making. BMJ 1999; 319: 766-771.
16. Heesen C Kasper J Segal J Köpke S Mühlhauser I. Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis. Mult Scler 2004; 10: 643-650.
17. Vickrey BG Shatin D Wolf SM. Management of multiple sclerosis across managed care and fee-for-service systems. Neurology 2000; 55: 1341-1349.
18. Steckelberg A Berger B Köpke S Heesen C Mühlhauser I. Kriterien für evidenzbasierte Patienteninformationen. [Criteria for evidence-based patient information] Z Arztl Fortbild Qualitatssich 2005; 99: 343-351.
19. Rogers R. A protection motivation theory of fear appeals and attitude change. J Psychol 1975; 91: 93-114.
20. Boer H Seydel ER. Protection motivation theory. In: M Connor P Norman, (eds), Predicting health behavior. Buckingham: Open University Press; 1996; 20: 95-120.
21. Meyer H. Unterichtsmethoden [Teaching methods]. Frankfurt: Cornelsen Scriptor; 1983.
22. Köpke S. Entwicklung eines Schulungsprogramms und Evaluationskonzepts zur Kortisonbehandlung im akuten Schub der Multiplen Sklerose [Development of an educational programme and evaluation concept for corticoid treatment in acute relapses of multiple sclerosis]. Hamburg: University of Hamburg; 2003 (state examination thesis).
23. Entwistle VA Skea ZC O'Donnell MT. Decisions about treatment: interpretations of two measures of control by women having a hysterectomy. Soc Sci Med 2001; 53: 721-732.
24. Gold SM Heesen C Schulz H. Disease specific quality of life instruments in multiple sclerosis: Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler 2001; 7: 119-130.
25. Sharrack B Hughes RA. The Guy's Neurological Disability Scale (GNDS): A new disability measure for multiple sclerosis. Mult Scler 1999; 5: 223-233.
26. Heesen C Reich C Borchers C Gold SM Schulz KH. Patientenbasierte Scoringsysteme bei Multipler Sklerose - Untersuchung zur Validierung der United Kingdom Disability Scale (UNDS) und des Patient-Generated-Index (PGI). [Patient based scoring instruments in multiple sclerosis - German validation of the United Kingdom Disability Scale (UNDS) and the Patient-Generated-Index (PGI)] Neurol Rehabil 2007; 13: 17-29.
27. Newcombe RG. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med 1998; 17: 2635-2650.
28. Mohr DC Hart SL Julian L Cox D Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: A meta-analysis. BMJ 2004; 328: 731-733.
29. Campbell M Fitzpatrick R Haines A. Framework for design and evaluation of complex interventions to improve health. BMJ 2000; 321: 694-696.
30. Lenz M Steckelberg A Richter B Mühlhauser I. Meta-analysis does not allow appraisal of complex interventions in diabetes and hypertension self-management: A methodological review. Diabetologia 2007; 50: 1375-1383.
31. Bekker H Thornton JG Airey CM. Informed decision making: An annotated bibliography and systematic review. Health Technol Assess 1999; 3: 1-156.
32. Kasper J Burisch G Geiger F Heesen C. Do patients perceive the involvement we observe? (abstract). In: Härter, M, Simon, D, Loh, A (eds), 4th International Shared Decision Making Conference. Lengerich: Pabst; 2007; 32: 147.
33. Elwyn G O'Connor A Stacey D. Developing a quality criteria framework for patient decision aids: Online international Delphi consensus process. BMJ 2006; 333: 417-419.
34. Newman S Steed L Mulligan K. Self-management interventions for chronic illness. Lancet 2004; 364: 1523-1537.